131I-MIBG Therapy Combined With High-Dose Chemotherapy as First-Line Treatment Improves Clinical Outcomes in Newly Diagnosed High-Risk Neuroblastoma: Single Institutional Experience

被引：0

作者：

Kuroda, Rie ^{[1
]}

Araki, Raita ^{[1
,4
]}

Noguchi, Kazuhiro ^{[1
]}

Fujiki, Toshihiro ^{[1
]}

Ikawa, Yasuhiro ^{[1
]}

Mase, Shintaro ^{[1
]}

Fukuda, Masaki ^{[1
]}

Wakabayashi, Hiroshi ^{[2
]}

Inaki, Anri ^{[2
]}

Kayano, Daiki ^{[2
]}

Sakai, Seisyo ^{[3
]}

Maeba, Hideaki ^{[1
]}

Nishimura, Ryosei ^{[1
]}

Kinuya, Seigo ^{[2
]}

Wada, Taizo ^{[1
]}

机构：

[1] Kanazawa Univ, Dept Pediat, Kanazawa, Ishikawa, Japan

[2] Kanazawa Univ, Dept Nucl Med Biotracer Med, Kanazawa, Ishikawa, Japan

[3] Kanazawa Univ, Dept Pediat Surg, Kanazawa, Ishikawa, Japan

[4] Ishikawa Prefectural Cent Hosp, Dept Pediat, Kanazawa, Ishikawa, Japan

来源：

PEDIATRIC BLOOD & CANCER | 2019年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OS43-3-5

引用

页码：S108 / S108

页数：1

共 50 条

[1] CLINICAL IMPACT OF HIGH-DOSE 131I-MIBG THERAPY ON PATIENTS WITH NEWLY DIAGNOSED HIGH-RISK NEUROBLASTOMA
Kuroda, Rie
Nishimura, Ryosei
Araki, Raita
Takenaka, Mika
Sakai, Yuta
Noguchi, Kazuhiro
Fujiki, Toshihiro
Ikawa, Yasuhiro
Wada, Taizo
PEDIATRIC BLOOD & CANCER, 2024, 71 : S14 - S15
[2] Effectiveness of high-dose 131I-MIBG as consolidation therapy for the patients with high-risk neuroblastoma
Inaki, A.
Kuroda, R.
Wakabayashi, H.
Akatani, N.
Yamase, T.
Kunita, Y.
Watanabe, S.
Hiromasa, T.
Mori, H.
Saito, S.
Ikawa, Y.
Kayano, D.
Kinuya, S.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S279 - S279
[3] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
Lessig, Megan Kinnear
JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
[4] I-131 MIBG AS A FIRST-LINE TREATMENT IN HIGH-RISK NEUROBLASTOMA PATIENTS
HOEFNAGEL, CA
DEKRAKER, J
OLMOS, RAV
VOUTE, PA
NUCLEAR MEDICINE COMMUNICATIONS, 1994, 15 (09) : 712 - 717
[5] Preliminary experience in treating high-risk neuroblastoma using tandem high dose dosimetry-guided 131I-MIBG treatment combined with chemotherapy
Boni, G.
Mazzarri, S.
Menconi, M.
Traino, A. C.
Borso, E.
Bernasconi, S.
Casazza, G.
Favre, C.
Volterrani, D.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S170 - S171
[6] Toxicity of 131I-MIBG combined with high-dose chemotherapy in children with refractory neuroblastoma.
Amoroso, L.
Villavecchia, G.
Cabria, M.
Piccardo, A.
Conte, M.
Nantron, M.
Garaventa, A.
De Bernardi, B.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[7] Feasibility and Efficacy of Treatment Strategy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation with Incorporation of High-Dose 131I-MIBG Therapy for High-Risk Neuroblastoma
Shin, J.
Koh, K. N.
Suh, J. K.
Min, S.
Kim, Y. S.
Namgoon, J. M.
Kim, D. Y.
Ahn, S. D.
Kim, H.
Im, H. J.
Seo, J. J.
Kook, H.
PEDIATRIC BLOOD & CANCER, 2019, 66 : S340 - S340
[8] Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with 131I-MIBG therapy for high-risk neuroblastoma
Suh, Jin Kyung
Koh, Kyung-Nam
Min, So Yoon
Kim, Young Sun
Kim, Hyery
Im, Ho Joon
Namgoong, Jung-Man
Kim, Dae Yeon
Ahn, Seung Do
Lee, Jong Jin
Seo, Jong Jin
PEDIATRIC TRANSPLANTATION, 2020, 24 (02)
[9] Sequential treatment of High-risk Neuroblastoma combining I-131 MIBG high-dose and Topotecan. First experience
Orrego, N.
Prado-Wohlwend, S.
Balaguer-Guill, J.
Torres-Espallardo, I.
Part-Lopez, M.
Guerrero-Calatayud, C.
Canon-Sanchez, J.
Montesinos-Gonzalez, S.
Bello-Arques, P.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S672 - S672
[10] Upfront Treatment of High-Risk Neuroblastoma With a Combination of 131I-MIBG and Topotecan
Kraal, Kathelijne C. J. M.
Tytgat, Godelieve A. M.
van Eck-Smit, Berthe L. F.
Kam, Boen
Caron, Huib N.
van Noesel, Max
PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 1886 - 1891

← 1 2 3 4 5 →